FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
{{output}}
Evidence from literature, including the BRIDGES study, indicates that germline protein truncating variants (PTVs) in FANCM confer moderately increased risk of ER-negative and triple-negative breast cancer (TNBC), especially for women with a family history of t... ...
